HFSA Annual Scientific Meeting 2025 OnDemand

50+ Expert-Led Heart Failure Sessions | Advanced HF • HFpEF • LVAD • Transplant • Cardiogenic Shock • AI & Digital Health

Stay current with major developments in heart failure diagnosis, treatment, research, devices, transplantation, mechanical circulatory support, and multidisciplinary care with the HFSA Annual Scientific Meeting 2025 OnDemand.

Developed from the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2025, this extensive educational collection features recordings of scientific sessions presented during one of the major professional meetings devoted specifically to heart failure.

The original HFSA Annual Scientific Meeting 2025 was held September 26–29, 2025 in Minneapolis, Minnesota.

The OnDemand curriculum includes 50+ expert-led sessions spanning practical clinical management, late-breaking research, emerging pharmacologic therapies, novel devices, LVAD care, heart transplantation, cardiogenic shock, HFpEF, cardiomyopathies, cardiac amyloidosis, cardio-oncology, cardiorenal disease, pulmonary hypertension, artificial intelligence, digital health, precision medicine, and end-of-life care.

The program is particularly relevant for physicians and multidisciplinary healthcare professionals involved in managing patients across the full spectrum of heart failure.

Course Details

• Course: HFSA Annual Scientific Meeting 2025 OnDemand
• Provider: Heart Failure Society of America – HFSA
• Year: 2025
• Original Meeting Dates: September 26–29, 2025
• Original Location: Minneapolis, Minnesota
• Specialty: Cardiology / Heart Failure
• Format: Digital / OnDemand Educational Content
• Sessions: 50+ Expert-Led Sessions
• Language: English
• Delivery: Google Drive
• MedicalAmboss CME / Certificate: Not Included

Course Overview

Heart failure management has evolved rapidly with advances in:

• Guideline-directed medical therapy
• HFpEF treatment
• Cardiogenic shock management
• Mechanical circulatory support
• LVAD technology
• Heart transplantation
• Cardiac amyloidosis
• Cardiomyopathy genetics
• Digital health
• Artificial intelligence
• Cardio-oncology
• Cardiorenal medicine
• Precision medicine
• Pulmonary hypertension
• Remote monitoring
• Novel drugs
• Gene therapy

The HFSA Annual Scientific Meeting 2025 OnDemand brings these areas together in a multidisciplinary curriculum designed around current challenges in heart failure care.

Rather than concentrating only on pharmacotherapy, the program follows patients across the entire heart failure pathway:

Risk & Prevention → Diagnosis → Guideline-Directed Therapy → Worsening HF → Hospitalization → Advanced HF → Devices / LVAD → Transplant → Palliation & End-of-Life Care

Learning Objectives

After reviewing the program, learners should be better able to:

• Describe the epidemiology and major risk factors associated with heart failure.
• Review strategies for heart failure prevention.
• Understand contemporary heart failure pathophysiology, including cardiovascular physiology, neurohormonal pathways, molecular biology, and genetics.
• Interpret recent heart failure clinical trials and understand their potential implications for practice.
• Apply guideline-directed pharmacologic therapy for heart failure.
• Incorporate nonpharmacologic treatments including diet, exercise, and appropriate device therapy.
• Manage important heart failure comorbidities.
• Review the relationship between heart failure and hypertension, diabetes, renal disease, obesity, sleep apnea, and other chronic conditions.
• Understand contemporary management of HFpEF.
• Evaluate patients with worsening and acute decompensated heart failure.
• Review modern approaches to cardiogenic shock.
• Understand temporary and durable mechanical circulatory support.
• Review LVAD complications and long-term LVAD management.
• Understand contemporary heart transplantation and post-transplant care.
• Review cardiac amyloidosis and inherited cardiomyopathies.
• Understand the growing role of AI and digital health in heart failure care.
• Review novel drugs, devices, and gene-based therapies.
• Improve transitions from inpatient to outpatient heart failure care.
• Apply multidisciplinary and patient-centered approaches to advanced heart failure management.
• Understand palliative care and end-of-life considerations.

Learning Highlights

50+ Expert-Led Sessions

The meeting provides an extensive review of contemporary heart failure medicine across clinical practice, research, devices, transplantation, digital health, and emerging therapeutics.

Late-Breaking Clinical Research

Dedicated plenary sessions review important new research involving:

• Novel therapies
• Cardiomyopathies
• Heart failure devices
• Emerging clinical trials
• Future treatment directions

Practical Heart Failure Management

Multiple sessions use:

• Clinical cases
• Rapid-fire presentations
• Debates
• Multidisciplinary discussions
• Practical management scenarios

to translate current evidence into clinical decision-making.

Advanced Heart Failure

Major advanced-HF topics include:

• Cardiogenic shock
• Temporary mechanical circulatory support
• LVAD
• Heart transplantation
• Right ventricular failure
• Mechanical ventilation
• Advanced therapies
• Donor selection
• Post-transplant management

Major Curriculum Areas

1. Guideline-Directed Medical Therapy & Worsening Heart Failure

The program provides extensive coverage of contemporary heart failure treatment.

Key topics include:

• Guideline-directed medical therapy – GDMT
• Decision support
• Outpatient worsening heart failure
• Heart failure hospitalization
• Congestion
• Novel medications
• Cost of advanced therapies
• Treatment controversies
• Readmission reduction

A Taylored Approach to Outpatient Management of Worsening Heart Failure

Reviews practical strategies for recognizing and managing worsening heart failure outside the hospital environment.

Important considerations include:

• Congestion
• Medication adjustment
• Early intervention
• Outpatient monitoring
• Prevention of hospitalization

Debates in Management of Worsening Heart Failure

Explores areas where different treatment strategies may be considered in patients with worsening disease.

This debate-based approach helps clinicians evaluate evidence rather than relying on a single standardized strategy.

Decoding Congestion in Heart Failure

Congestion remains one of the central clinical problems in heart failure.

The session reviews evolving approaches to:

• Volume assessment
• Hemodynamic evaluation
• Decongestion
• Clinical monitoring
• Treatment response

2. HFpEF

Heart failure with preserved ejection fraction remains one of the most complex areas of cardiovascular medicine.

Relevant sessions include:

Practical Guide to the HFpEF Galaxy

A clinically oriented review of:

• HFpEF diagnosis
• Phenotyping
• Comorbidities
• Treatment
• Clinical decision-making

Inflammation & Fibrosis in HFpEF

Reviews evolving biological mechanisms that may contribute to HFpEF development and progression.

3. Cardiogenic Shock

The meeting contains multiple sessions addressing contemporary shock management.

2025 ACC Expert Consensus Statement on the Evaluation and Management of Cardiogenic Shock

A focused discussion of current concepts related to:

• Cardiogenic shock recognition
• Risk assessment
• Hemodynamics
• Treatment
• Mechanical circulatory support
• Multidisciplinary care

Multidisciplinary Approach to Cardiogenic Shock in the CICU

Reviews the importance of coordinated care involving:

• Heart failure specialists
• Interventional cardiologists
• Intensivists
• Cardiothoracic surgeons
• Mechanical support teams
• Nursing
• Other members of the shock team

Temporary Mechanical Circulatory Support in Cardiogenic Shock

Examines contemporary approaches to temporary support and patient selection.

4. LVAD & Mechanical Circulatory Support

LVAD Complications

Reviews the evolving complications associated with durable mechanical circulatory support.

Important areas may include:

• Device complications
• Hemocompatibility
• Infection
• Bleeding
• Thrombosis
• Right ventricular failure
• Long-term management

New Frontiers in LVAD Care

Examines evolving approaches designed to improve outcomes and quality of life for patients receiving long-term LVAD support.

Right Ventricular Failure & Right-Sided Mechanical Support

The curriculum also reviews the challenging interaction between:

• RV failure
• Mechanical ventilation
• Pulmonary circulation
• Right-sided mechanical circulatory support

5. Heart Transplantation

Heart transplantation remains a major component of advanced heart failure management.

Sessions address:

• Donor selection
• Expansion of the donor pool
• Transplant monitoring
• Long-term post-transplant management
• Noncardiac comorbidities
• New technologies

New Technologies for Heart Transplant Monitoring

Reviews evolving tools that may improve surveillance after transplantation.

Towards a Larger Donor Pool

Examines strategies designed to increase access to donor hearts and potentially expand transplant eligibility.

Long-Term Noncardiac Comorbidities in Heart Recipients

Transplant success requires long-term management extending beyond graft function.

The program reviews medical problems affecting heart-transplant recipients after successful transplantation.

6. Cardiac Amyloidosis

The 2025 curriculum includes dedicated cardiac amyloidosis education.

Mastering High-Level Cardiac Amyloidosis Care

Reviews contemporary approaches to complex amyloidosis management.

Mayhem in Cardiac Amyloidosis

Provides additional case-oriented review of challenging amyloidosis scenarios.

Topics may include:

• Diagnosis
• Imaging
• Clinical phenotype
• Treatment
• Multidisciplinary management

7. Cardiomyopathies

The meeting addresses multiple forms of cardiomyopathy.

Topics include:

• Genetic cardiomyopathy
• Inflammatory cardiomyopathy
• Hypertrophic cardiomyopathy
• Amyloid cardiomyopathy
• Device therapy
• Advanced treatment

Cardiomyopathy: Is It All Genetic?

Reviews the growing role of genetics in cardiomyopathy evaluation and management.

Inflammatory Cardiomyopathies

Examines inflammatory causes of myocardial disease and their diagnostic and therapeutic challenges.

Hypertrophic Cardiomyopathy

Dedicated content reviews contemporary approaches to pressure relief and disease management in hypertrophic cardiomyopathy.

8. Atrial Fibrillation & Heart Failure

Atrial Fibrillation in Patients with Heart Failure: Out of Rhythm and Out of Breath

Reviews the frequent coexistence of AF and HF.

Important clinical questions include:

• Rate control
• Rhythm control
• Anticoagulation
• Hemodynamic impact
• Patient selection
• Heart failure outcomes

9. Cardiorenal Syndrome

Contemporary Issues in Heart Failure and Kidney Disease: The Cardiorenal Connection

Heart failure and renal dysfunction frequently coexist.

The program reviews:

• Cardiorenal interactions
• Renal function
• Diuretic therapy
• Medication selection
• Treatment challenges
• Risk assessment

10. Cardio-Oncology

Cardio-Oncology & Heart Failure: Balancing Cancer Survival and Heart Success

Cancer therapy can create important cardiovascular complications.

The session examines the intersection between:

• Oncology treatment
• Cardiovascular toxicity
• Heart failure
• Cancer survivorship
• Multidisciplinary management

11. Artificial Intelligence & Digital Health

Artificial intelligence and digital technology represent major emerging areas in heart failure care.

Digital Health & Artificial Intelligence: Success Strategies for Implementation

Reviews practical considerations involved in implementing:

• Digital health tools
• AI systems
• Remote monitoring
• Clinical decision support
• Workflow technologies

Heart Failure AI in 2025: Are We Getting More Intelligent?

Examines the current state of artificial intelligence in heart failure.

Potential applications include:

• Risk prediction
• Phenotyping
• Diagnostic support
• Remote monitoring
• Clinical decision support
• Population management

12. Precision Medicine, Bio-Omics & Phenotyping

Clinical Bio-Omics for Precision Health in Heart Failure

Reviews how modern molecular and biological datasets may contribute to individualized heart failure care.

Relevant concepts include:

• Biomarkers
• Genomics
• Molecular profiling
• Precision medicine
• Risk stratification

Phenotyping Group 2 Pulmonary Hypertension

Explores how more precise patient characterization may help guide management of pulmonary hypertension associated with left heart disease.

13. Heart Failure Devices

The Rise of Heart Failure Devices

Reviews the rapidly expanding range of implantable and interventional technologies used in heart failure care.

Interatrial Shunts in Heart Failure

Examines the rationale and evolving evidence surrounding interatrial shunt technologies.

Novel HF Therapies & Right Heart Function

Reviews emerging therapies and their implications for the right ventricle and pulmonary circulation.

14. Pulmonary Hypertension & Right Heart Failure

Relevant topics include:

• Group 2 pulmonary hypertension
• Right ventricular dysfunction
• Mechanical ventilation
• Right-sided circulatory support
• Heart-lung interactions
• Advanced heart failure

15. Obesity, Nutrition & Exercise

Obesity Management in Heart Failure

Reviews the increasingly important relationship between obesity and heart failure.

Topics include:

• Obesity phenotype
• HFpEF
• Weight management
• Cardiometabolic risk
• Therapeutic strategies

Diet and Exercise in Heart Failure

Reviews practical applications of:

• Exercise
• Rehabilitation
• Nutrition
• Lifestyle modification

within comprehensive heart failure care.

Heart Failure & the Microbiome

Explores emerging research involving diet, gut biology, and heart failure.

16. Heart Failure During Pregnancy

Heart Failure During Pregnancy & Beyond: Breathing for Two

Reviews the unique challenges of cardiovascular and heart failure management during pregnancy and the postpartum period.

17. Sex Differences in Heart Failure

The meeting includes dedicated sessions addressing differences in:

• Heart failure presentation
• Epidemiology
• Biology
• Treatment
• Clinical outcomes

between patient populations.

18. Adult Congenital Heart Disease

Advancing the Management of Heart Failure in Adult Congenital Heart Disease

Reviews complex heart failure management in adults living with congenital heart disease.

Topics include:

• Advanced therapies
• Timing of intervention
• Multidisciplinary care
• Long-term management

19. Novel Drugs & Gene Therapy

Novel Drugs and Gene Therapy: What’s Next?

Explores emerging therapies that may shape future heart failure management.

The session helps clinicians understand the evolving therapeutic pipeline beyond established GDMT.

20. Palliation & End-of-Life Care

A Compassionate Journey Through Caregiving, Patient Perspectives, Palliation, and End of Life

Reviews patient-centered issues surrounding advanced disease.

Debunking Myths About End-of-Life Care in Heart Failure

Addresses misconceptions surrounding:

• Palliative care
• Hospice
• Advanced care planning
• Patient preferences
• Caregiver support
• End-stage heart failure

Plenary & Late-Breaking Research Sessions

Saturday Plenary

HFSA at 30 Years: Past, Present, and Future

Reviews three decades of advances in heart failure science and care while examining future directions in the specialty.

Sunday Plenary

Late-Breaking Clinical Research 1: Devices and Cardiomyopathies

Highlights emerging evidence involving:

• Cardiomyopathies
• Devices
• Advanced therapies
• Clinical trials

Monday Plenary

Late-Breaking Clinical Research 2: Novel Therapies

Focused on new therapeutic strategies and research that may influence future heart failure practice.

Rapid-Fire Sessions

The curriculum also includes rapid-update sessions focused on:

• Transplant and VADs
• Medications
• Devices and digital technologies
• Clinical trials
• Inflammation and fibrosis in HFpEF

These sessions provide concise reviews of multiple evolving areas.

Selected HFSA 2025 Sessions

The MedicalAmboss product includes topics such as:

• 2025 ACC Expert Consensus Statement on Cardiogenic Shock
• A Compassionate Journey Through Caregiving, Palliation & End of Life
• Outpatient Management of Worsening Heart Failure
• Heart Failure in Adult Congenital Heart Disease
• Atrial Fibrillation in Heart Failure
• Cardio-Oncology & Heart Failure
• Genetics of Cardiomyopathy
• Clinical Bio-Omics for Precision Health
• Heart Failure and Kidney Disease
• Cost of Novel Heart Failure Therapies
• Worsening Heart Failure Management Debates
• Congestion in Heart Failure
• Diet and Exercise
• Digital Health & Artificial Intelligence
• GDMT Decision Support
• Heart Failure Admissions
• AI in Heart Failure
• Heart Failure and the Microbiome
• Heart Failure During Pregnancy
• Heart Recovery
• Inflammatory Cardiomyopathies
• Interatrial Shunts
• LVAD Complications
• Cardiac Amyloidosis
• Cardiogenic Shock in the CICU
• New Frontiers in LVAD Care
• Heart Transplant Monitoring
• Novel Drugs and Gene Therapy
• Right Heart Function
• Obesity and Heart Failure
• HFpEF
• Heart Transplantation
• Mechanical Circulatory Support
• Hypertrophic Cardiomyopathy
• Pulmonary Hypertension
• Sex Differences in Heart Failure
• Late-Breaking Clinical Research
• Novel Devices
• Precision Heart Failure Medicine

Major Topics Covered

• Heart Failure
• Advanced Heart Failure
• Acute Heart Failure
• Chronic Heart Failure
• Worsening Heart Failure
• HFpEF
• HFrEF
• Guideline-Directed Medical Therapy
• GDMT
• Cardiogenic Shock
• Mechanical Circulatory Support
• LVAD
• Ventricular Assist Devices
• Heart Transplantation
• Cardiac Amyloidosis
• Cardiomyopathy
• Hypertrophic Cardiomyopathy
• Inflammatory Cardiomyopathy
• Atrial Fibrillation
• Cardiorenal Syndrome
• Pulmonary Hypertension
• Right Heart Failure
• Cardio-Oncology
• Artificial Intelligence
• AI in Cardiology
• Digital Health
• Precision Medicine
• Bio-Omics
• Genetics
• Heart Failure Devices
• Interatrial Shunts
• Obesity
• Exercise
• Nutrition
• Heart Failure in Pregnancy
• Palliative Care
• End-of-Life Care
• Clinical Trials
• Novel Drugs
• Gene Therapy

Who Should Take This Course?

The HFSA Annual Scientific Meeting 2025 OnDemand is intended for the multidisciplinary heart failure care team.

It is particularly relevant for:

• Cardiologists
• Heart Failure Specialists
• Advanced Heart Failure Cardiologists
• Heart Transplant Cardiologists
• Cardiovascular Physicians
• Internal Medicine Physicians
• Critical Care Physicians
• Cardiovascular Nurses
• Nurse Practitioners
• Physician Assistants / Associates
• Pharmacists
• Clinical Scientists
• Researchers
• Cardiovascular Fellows
• Cardiology Fellows
• Residents
• Mechanical Circulatory Support Teams
• Transplant Teams
• Healthcare professionals with an interest in heart failure

Why This Course Is Useful

One of the primary strengths of HFSA Annual Scientific Meeting 2025 is its breadth.

The program moves far beyond a standard heart failure pharmacology update and covers the entire clinical spectrum:

Prevention → GDMT → HFpEF → Worsening HF → Cardiogenic Shock → Devices → LVAD → Transplant → Precision Medicine → AI → Emerging Therapies → Palliation

This makes the course useful for clinicians who want to:

• Update heart failure management knowledge
• Review HFpEF
• Improve GDMT implementation
• Review cardiogenic shock
• Understand temporary MCS
• Update LVAD knowledge
• Review heart transplantation
• Improve cardiac amyloidosis management
• Review complex cardiomyopathies
• Understand cardio-oncology
• Review cardiorenal syndrome
• Explore AI and digital health
• Review precision medicine
• Stay current with late-breaking clinical trials
• Learn about novel drugs and gene therapy
• Improve multidisciplinary advanced-HF care
• Review palliative and end-of-life management

Product / Delivery Information

• Product: HFSA Annual Scientific Meeting 2025
• Provider: Heart Failure Society of America – HFSA
• Year: 2025
• Original Meeting: September 26–29, 2025
• Location: Minneapolis, Minnesota
• Specialty: Cardiology / Heart Failure
• Sessions: 50+
• Format: Digital Educational Content
• Delivery: Google Drive
• CME / Certificate with MedicalAmboss Product: Not Included
• Language: English

Important CME / Certificate Notice

The official HFSA OnDemand activity has separate continuing-education accreditation and claim requirements through HFSA.

However, the MedicalAmboss product page explicitly states that no CME points or certificate are associated with the independently delivered course files.

Therefore, the MedicalAmboss product should not be advertised as including:

• HFSA CME Credits
• ABIM MOC Points
• Nursing CE
• Pharmacy CE
• AAPA CME
• Official HFSA Certificate

unless official HFSA registration and credit-claiming access are actually being supplied.

4. Short Description

HFSA Annual Scientific Meeting 2025 OnDemand provides 50+ expert-led heart failure sessions covering contemporary and advanced cardiovascular care.

Topics include GDMT, HFpEF, worsening heart failure, cardiogenic shock, LVAD, mechanical circulatory support, heart transplantation, cardiac amyloidosis, cardiomyopathies, atrial fibrillation, cardiorenal syndrome, cardio-oncology, pulmonary hypertension, AI and digital health, obesity, precision medicine, novel devices, gene therapy, and late-breaking clinical trials.

Provider: Heart Failure Society of America – HFSA
Original Meeting: September 26–29, 2025
Location: Minneapolis, Minnesota
Delivery: Google Drive
CME / Certificate: Not included with the MedicalAmboss digital product

 

+ Topics:

• 2025 ACC Expert Consensus Statement on the Evaluation and Management of Cardiogenic Shock- Fireside Chat

• A Compassionate Journey Through Caregiving, Patient Perspectives, Palliation, and End of Life- The Circle of Life

• A Taylored Approach to Outpatient Management of Worsening Heart Failure

• Advancing the Management of Heart Failure in Adult Congenital Heart Disease- Innovations, Timeliness, and Advanced Therapies

• Atrial Fibrillation in Patients with Heart Failure- Out of Rhythm and Out of Breath

• Cardio-Oncology & Heart Failure- Balancing Cancer Survival and Heart Success

• Cardiomyopathy- Is It All Genetic..

• Clinical Bio-Omics for Precision Health in Heart Failure

• Contemporary Issues in Heart Failure and Kidney Disease- The Cardiorenal Connection

• Cost of Novel Heart Failure Therapies Is the Juice Worth the Squeeze

• Debates in Management of Worsening of Heart Failure- Which Path Do You Take..

• Debunking Myths About End-of-Life Care in Heart Failure- Not Just End of Life

• Decoding Congestion in Heart Failure- Novel Insights for Clinicians in 30 Minutes

• Diet and Exercise in Heart Failure- Don’t Sweat It

• Digital Health & Artificial Intelligence- Success Strategies for Implementation

• GDMT Decision Support for the Health System, the Clinician, or the Patient. Who Needs the Nudge..

• Heart Failure Admissions- New Ideas for Dylan with an Old Problem

• Heart Failure AI in 2025- Are We Getting More Intelligent..

• Heart Failure and the Microbiome- You Are What You Eat

• Heart Failure During Pregnancy & Beyond- Breathing for Two

• Heart Failure Is Too Big to Fail

• Heart Recovery- Just the Facts, Ma’am

• How Do Program Leaders Define Heart Failure Success in 2025

• Inflammatory Cardiomyopathies- Getting it Right

• Interatrial Shunts in Heart Failure- Pressure Is a Privilege

• Jay N. Cohn (JNC) New Investigator Award Presentations

• LVAD Complications- The Times They Are A-Changing

• Making Heart Failure Data Count- HFSA Stats Call to Action!

• Managing Long-Term, Non-Cardiac Comorbidities in Heart Recipients- I Got a Heart! Now What..

• Mastering High-Level Cardiac Amyloidosis Care

• Mayhem in Cardiac Amyloidosis

• Monday Plenary Session- Late Breaking Clinical Research 2- Novel Therapies

• Multidisciplinary Approach to Cardiogenic Shock in CICU- By Our Powers Combined!

• New Frontiers in LVAD Care- Live Long and Prosper

• New Technologies for Heart Transplant Monitoring- Heart Tank

• Nothing Compares 2 This Case- 2nd Annual Case Competition

• Novel Drugs and Gene Therapy- What’s Next..

• Novel HF Therapies and Right Heart Function – Let’s Do Right by the Right Heart

• Obesity Management in Heart Failure- Tipping the Scales

• Practical Guide to the HFpEF Galaxy

• Rapid Fire Session 1- Transplant and VADs

• Rapid Fire Session 2 – Medications

• Rapid Fire Session 3- Devices and Digital

• Rapid Fire Session 4- Trials

• Rapid Fire- Inflammation & Fibrosis in HFpEF

• Relieving the Pressure in Hypertrophic Cardiomyopathy

• RV Failure, Mechanical Ventilation, and Right-Sided MCS- Heart-Lung and The Machines

• Saturday Plenary Session- 30 Years of HFSA – Past, Present, and Future

• Sex Differences in Heart Failure- Learn From the Experts!

• Sex-Based Differences in Heart Failure

• Sunday Plenary Session- Late Breaking Clinical Research 1- Devices and Cardiomyopathies

• Temporary Mechanical Circulatory Support in Cardiogenic Shock- Optimizing Outcomes

• The Heart of the Matter- Nurse Award Presentation

• The Rise of Heart Failure Devices- Calling All Avengers

• Towards a Larger Donor Pool- Deeper and Wider

• Using Phenotyping to Guide Treatment in Group 2 Pulmonary Hypertension- Are We Out of the Woods Yet..

• What’s the Tea! Hot Topics in Heart Function at JCF